Serum amyloid a levels in kidney-transplanted patients with familial Mediterranean fever-amyloidosis

Israel Medical Association Journal

Volumn 13, Issue 4, 2011, Pages 202-205

  Kivity, Shaye ^a   Danilesko, Iveta ^a   Ben Zvi, Ilan ^a   Gilburd, Boris ^a   Kukuy, Olga L ^b   Rahamimov, Ruth ^c,d   Livneh, Avi ^b,d  

^a SHEBA MEDICAL CENTER   (Israel)

^b HELLER INSTITUTE OF MEDICAL RESEARCH   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Amyloidosis; Colchicine; Familial Mediterranean fever; Kidney transplantation; Serum amyloid A

Indexed keywords

AMYLOID A PROTEIN; C REACTIVE PROTEIN;

ADULT; AGE DISTRIBUTION; AMYLOIDOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; ETHNICITY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE; GENE MUTATION; GENETIC RISK; GRAFT RECIPIENT; HUMAN; KIDNEY TRANSPLANTATION; MALE; MEFV GENE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SEX DIFFERENCE;

AMYLOID; AMYLOIDOSIS; CROSS-SECTIONAL STUDIES; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RISK FACTORS;

EID: 79957595420     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Drenth JP, van der Meer JW. Hereditary periodic fever N Engl J Med 2001; 345 (24): 1748-57.
2. Lachmann HJ, Goodman HJ, Gilbertson JA, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med 2007; 356 (23): 2361-71.
3. Yakar S, Livneh A, Kaplan B, Pras M. The molecular basis of reactive amyloidosis. Semin Arthritis Rheum 1995; 24 (4): 255-61.
4. Livneh A, Langevitz P, Zemer D, et al. The changing face of familial Mediterranean fever. Semin Arthritis Rheum 1996; 26 (3): 612-27.
5. Lidar M, Livneh A. Familial Mediterranean fever: clinical, molecular and management advancements. Neth J Med 2007; 65 (9): 318-24.
6. Jovanovic DB. Clinical importance of determination of serum amyloid A. Srp Arh Celok Lek 2004; 132 (7-8): 267-71.
7. van der Hilst JC, Simon A, Drenth JP. Hereditary periodic fever and reactive amyloidosis. Clin Exp Med 2005; 5 (3): 87-98.
8. Berkun Y, Padeh S, Reichman B, et al. A single testing of serum amyloid a levels as a tool for diagnosis and treatment dilemmas in familial Mediterranean fever. Semin Arthritis Rheum 2007; 37 (3): 182-8.
9. Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40 (10): 1879-85.
10. Mor A, Shinar Y, Zaks N, et al. Evaluation of disease severity in familial Mediterranean fever. Semin Arthritis Rheum 2005; 35 (1): 57-64.
11. Duzova A, Bakkaloglu A, Besbas N, et al. Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever. Clin Exp Rheumatol 2003; 21 (4): 509-14.
12. Casl MT, Bulatovic G, Orlic P, Sabljar-Matovinovic M. The diagnostic capacity of serum amyloid A protein for early recognition of kidney allograft rejection. Nephrol Dial Transplant 1995; 10 (10): 1901-4.
13. Fukuda Y, Hoshino S, Tanaka I, et al. Examination of serum amyloid A protein in kidney transplant patients. Transplant Proc 2000; 32 (7): 1796-8.